Immunotoxins
Showing 51 - 61 of 61
Brain and CNS Tumors Trial (cintredekin besudotox, conventional surgery)
Withdrawn
- Brain and Central Nervous System Tumors
- cintredekin besudotox
- conventional surgery
- (no location specified)
Sep 23, 2010
Leukemia, Lymphoma Trial run by the (BL22 immunotoxin, antibody-drug conjugate therapy, immunotoxin therapy)
Completed
- Leukemia
- Lymphoma
- BL22 immunotoxin
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Jun 17, 2010
Acute GVHD Trial in Nijmegen, Rotterdam, Utrecht (IT-Combination)
Withdrawn
- Acute Graft Versus Host Disease
- IT-Combination
-
Nijmegen, Netherlands
- +2 more
Apr 28, 2009
Lymphoma Trial in United States (denileukin diftitox)
Completed
- Lymphoma
- denileukin diftitox
-
Chicago, Illinois
- +9 more
Jan 26, 2010
Brain and CNS Tumors Trial in United States (TGFa-PE38 immunotoxin, conventional surgery)
Terminated
- Brain and Central Nervous System Tumors
- TGFa-PE38 immunotoxin
- conventional surgery
-
Washington, District of Columbia
- +7 more
Oct 20, 2009
B Cell Lymphoma Trial run by the NCI (IgG-RFB4-SMPT-dgA)
Completed
- B Cell Lymphoma
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Leukemia, Lymphoma Trial run by the (BL22 immunotoxin, antibody-drug conjugate therapy, immunotoxin therapy)
Suspended
- Leukemia
- Lymphoma
- BL22 immunotoxin
- +3 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Dec 21, 2007
Leukemia, Non-Hodgkin's Lymphoma, NHL Trial in Beverly Hills, Bethesda, Lodz (Immunotoxin therapy, CAT-8015 Immunotoxin,
Unknown status
- Leukemia
- +2 more
- Immunotoxin therapy
- +4 more
-
Beverly Hills, California
- +2 more
Aug 10, 2007
Leukemia Trial in Poland, United States (Immunotoxin therapy, CAT-8015 immunotoxin, Biological therapy)
Unknown status
- Leukemia
- Immunotoxin therapy
- +2 more
-
Beverly Hills, California
- +3 more
Apr 16, 2007
Leukemia, Hairy Cell Leukemia, HCL Trial in Poland, United Kingdom, United States (Immunotoxin therapy, CAT-8015 Immunotoxin,
Unknown status
- Leukemia
- +2 more
- Immunotoxin therapy
- +2 more
-
Stanford, California
- +4 more
Apr 16, 2007